AstraZeneca flop a fresh blow to cancer immunotherapy combination Ruby Khatun Khatun26 April 2018 9:30 AM ISTLONDON: The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has...
Dr Reddy's gets EIR from USFDA for UK plant Ruby Khatun Khatun25 April 2018 10:30 AM ISTNew Delhi: Dr Reddy's Laboratories said it has received an establishment inspection report (EIR) from the US health regulator after audit of its UK...
UK bans Sanofi epilepsy drug without pregnancy prevention plan Ruby Khatun Khatun25 April 2018 9:45 AM ISTLONDON: A Sanofi drug for epilepsy and bipolar disorder linked to thousands of birth defects has been banned in Britain for use in women or girls of...
Express Scripts targets Amgen, Lilly migraine drugs in pricing shift Ruby Khatun Khatun25 April 2018 9:30 AM ISTLOS ANGELES: The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen...
Bankrupt Orchid Pharma Rejects Only Bid for being too low Ruby Khatun Khatun24 April 2018 5:21 PM ISTNew Delhi: Orchid pharma has invited a fresh bidding after the company has found the only eligible bid for takeover of the company to be low.The...
Lupin gets USFDA nod to market Tetrabenazine tablets Ruby Khatun Khatun24 April 2018 10:15 AM ISTNew Delhi: Drug firm Lupin said it has received approval from the US health regulator to market in America its Tetrabenazine tablets used for the...
GSK Consumer Healthcare appoints Rahul Kapoor as Executive Vice President-HR Ruby Khatun Khatun24 April 2018 10:00 AM ISTNew Delhi: GSK Consumer Healthcare said it has appointed Rahul Kapoor as executive vice-president-HR for India sub-continent (ISC) region.Kapoor will...
FDA panel against higher dose of Lilly-Incyte arthritis drug Ruby Khatun Khatun24 April 2018 9:45 AM ISTAn arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted, in a...
FDA declines to approve Pfizer biosimilar of Roche's cancer drug Ruby Khatun Khatun24 April 2018 9:30 AM ISTPfizer Inc said U.S. regulators declined to approve the company’s biosimilar of Roche’s blockbuster treatment for breast cancer, Herceptin and sought...
PIL in HC against new tender to empanel chemists under CGHS Ruby Khatun Khatun23 April 2018 10:30 AM ISTNew Delhi: The Delhi High Court has sought the response of the Centre on a PIL challenging an e-tender issued for empanelment of authorised local...
Novartis appoints John Tsai as Head of Global Drug Development and CMO Ruby Khatun Khatun23 April 2018 10:15 AM ISTBasel: Novartis announced the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer.Dr. Tsai will join...
Merck seeks partners for cancer and immune system drugs Ruby Khatun Khatun23 April 2018 10:00 AM ISTFRANKFURT: Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to...
